THX Pharma Société Anonyme (ALTHX)

Profile

https://www.theranexus.com

THX Pharma Société Anonyme is a French biopharmaceutical company focused on developing treatments for rare neurological diseases and central nervous system disorders. The company works on drug candidates designed to address conditions with limited therapeutic options, with a particular emphasis on innovative approaches that target both neuronal and glial cell interactions. Its current pipeline includes Batten-1, developed for Batten disease and evaluated in clinical studies. THX Pharma also maintains a broader research platform centered on identifying and characterizing new therapeutic candidates for neurology. Headquartered in Lyon, France, THX Pharma operates at the intersection of biotechnology and pharmaceutical development, serving a specialized role in rare-disease research and drug innovation.